Ligand validation:3ZV7

MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3ZV7_MES_A_1542	2%	34%	0.45	0.72	1.47	1.16	1	-	1	0	100%	0.5
2WG1_MES_A_608	77%	21%	0.122	0.962	1.96	1.36	1	2	1	0	100%	0.8
2DFP_MES_A_4001	64%	0%	0.156	0.954	8.3	2.64	7	6	0	0	100%	1
2WG0_MES_A_2541	35%	19%	0.185	0.871	1.59	1.85	3	4	1	0	100%	0.9
2CEK_MES_A_601	29%	32%	0.196	0.854	1.48	1.22	1	2	1	0	100%	1
1HBJ_MES_A_1540	26%	0%	0.241	0.883	8.76	2.54	8	6	0	0	100%	1
2IUY_MES_B_1355	100%	9%	0.026	0.997	1.73	2.73	1	7	0	0	100%	1
3DPJ_MES_A_192	100%	8%	0.022	0.995	2.2	2.41	1	6	3	0	100%	1
5A0C_MES_B_1002	100%	11%	0.033	0.993	1.84	2.39	3	3	0	0	100%	1
8AJQ_MES_H_201	100%	38%	0.037	0.992	1.52	0.93	1	1	0	0	100%	1
5APG_MES_A_1187	100%	12%	0.044	0.99	1.48	2.57	3	6	0	0	100%	0.9292

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.